Program

Thursday, 21 November 2024

13:00

Registration

13:40 – 13:50

Opening/Welcome

René Leemans

Andreas Dietz

Wojciech Golusiński

SESSION 1: Update on worldwide incidence of HPV

in head and neck

Chair: Wojciech Golusiński

13:50 – 14:10

Current epidemiology of HPV infection

in oropharyngeal cancer

Hisham Mehanna

14:10 – 14:30

The current status of HPV epidemiology in South America

Luiz Paulo Kowalski

14:30 – 14:50

Latest discoveries in HPV-related carcinogenesis

Rudd Brakenhof

14:50 – 15:20

COFFEE

14:50 – 15:20

SESSION 2

Chair: Andreas Dietz

15:20 – 15:50

At a crossroad: clinical trials for HPV-positive oropharyngeal carcinoma

Chris Holsinger

15:50 – 16:10

Altered immunomodulatory role of innate immune cells in HPV-positive and HPV-negative head and neck cancer

Stephan Lang

16:10 – 17:00

FREE PAPERS

Chair: Michał Masternak

Agnieszka Mazurek

Tomasz Rutkowski

Urszula Kacorzyk

Elisabetta Fratta

Friday, 22 November 2024

SESSION 3: Management of HPV+ve oropharyngeal cancer

Chair: René Leemans

9:00 – 9:20

Worldwide incidence of HPV in non-oropharyngeal cancer

Paweł Golusiński

9:20 – 9:40

Treatment of HPV disease by transoral robotic surgery

Christian Simon

9:40 – 10:00

HPV positivity does not influence the surgical technique in oropharyngeal carcinoma

Andreas Dietz

10:00 – 10:20

AI, robotics and innovation in head and neck oncology

Chris Holsinger

10:20 – 10:45

FREE PAPERS x 2

Chair: Sefik Hosal

Paweł Golusiński

Faizan Shah

10:45 – 11:15

COFFEE

SESSION 4

Chair: Hisham Mehanna

11:15 – 12:15

Debate: T1-T2 oropharyngeal treatment surgery/non-surgery: for-against

For: Giovanni Succo

Against: Sefik Hosal

12:15 – 12:45

De-escalation treatment of oropharyngeal cancer – state of art

Robert Ferris

12:45 – 13:05

Salvage surgery following treatment failure in HPV-positive disease

René Leemans

13:05 – 13:20

Young European Head and Neck Society – introduction and future aims

Paweł Golusiński,

Irene Nauta

13:20 – 14:20

LUNCH

SESSION 5

Chair: Luiz Paulo Kowalski

14:20 – 14:40

Differences in imaging evaluation in HPV-positive and

HPV-negative head and neck tumors

Piotr Radomyski

14:40 – 15:10

Neoadjuvant immunotherapy for patients with resectable HPV-positive and HPV-negative squamous cell carcinomas in head and neck

Robert Ferris

15:10 – 15:30

Is proton therapy preferable for HPV-positive OPSCC?

Jeppe Friborg

15:30 – 15:50

The impact of TNM8 classification on our daily clinical practice

Hisham Mehanna

15:50 – 16:10

HPV in non-oropharygeal HNSCC: does it play a role?

Gunnar Wichmann

16:10 - 16:40

COFFEE

SESSION 6

Chair: Jeppe Friborg

16:40-17:00

Treatment of HPV disease with (chemo)radiotherapy

Joanna Kaźmierska

17:00 – 17:20

Ongoing clincial trials in HPV-positive oropharyngeal cancers

Paolo Bossi

17:20 – 17:40

TOUSS in oropharyngeal surgery

Mario Fernandez-Fernandez

17:40 – 18:00

Transoral approach to the oropharynx alternative to TORS: technical refinements

Giovanni Succo

Office of the Organizer

Kinga Lunitz – Coordinator
15 Garbary St., 61-866 Poznan
Phone: +48 61 88 50 929
e-mail: kinga.lunitz@wco.pl

Venue

Congress and Education Center
Medical University of Karol Marcinkowski in Poznań
St. Przybyszewskiego 37a
60-356 Poznań/ POLAND